AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10496553 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with acquired immunodeficiency syndrome
Number of subjects: 48
Study 10496553 — intervention group
Group type: COMPARATOR
Intervention: Control group (seronegative patients)
Number of subjects: 48
Study 8983893 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 163
Study 8983893 — intervention group
Group type: COMPARATOR
Intervention: Ceftibuten
Number of subjects: 163
Study 8983893 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 163
Study 1917174 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous treatment (two 10 mg/24 hour patches twice daily, at 8 a.m. and 8 p.m.)
Number of subjects: 88
Study 1917174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent treatment (two 10 mg/24 hour patches at 8 a.m. and two placebo patches at 8 p.m.)
Number of subjects: 88
Study 1917174 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two placebo patches twice daily, at 8 a.m. and 8 p.m.)
Number of subjects: 88
Study 6461943 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 18
Study 6461943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 31169226 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) scan
Number of subjects: 59
Study 31169226 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative PET-CT at the first follow-up
Number of subjects: 59
Study 31169226 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline maximum standardized uptake value (SUVmax)
Number of subjects: 59
Study 31169226 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall accuracy of PET-CT
Number of subjects: 59
Study 27730252 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted feedback
Number of subjects: 100
Study 27730252 — intervention group
Group type: COMPARATOR
Intervention: Oral feedback
Number of subjects: 100
Study 26399403 — intervention group
Group type: EXPERIMENTAL
Intervention: Asleep systolic ABP mean
Number of subjects: 2656
Study 26399403 — intervention group
Group type: COMPARATOR
Intervention: Daytime clinic BP and awake or 48 h ABP mean
Number of subjects: 2656
Study 24393491 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 1: Basic feedback regarding clients' symptoms and quality of life
Number of subjects: 432
Study 24393491 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 2: Extended feedback with obstacles and practical suggestions
Number of subjects: 432
Study 24393491 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition 3: Feedback discussed with a colleague using a standardized format
Number of subjects: 432
Study 21987650 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphenoidal process length measurement during septal surgery
Number of subjects: 136
Study 21987650 — intervention group
Group type: EXPERIMENTAL
Intervention: Deviation angle measurement at the ostiomeatal unit
Number of subjects: 136
Study 21987650 — intervention group
Group type: EXPERIMENTAL
Intervention: Deviation angle measurement at the nasal valve area
Number of subjects: 136
Study 21987650 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of ANS-PPE measurement
Number of subjects: 136
Study 21987650 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of ANS-CS measurement
Number of subjects: 136
Study 19664956 — intervention group
Group type: COMPARATOR
Intervention: Standard topical 4% lidocaine cream and injection of [(99m)Tc]Tc‐sulfur colloid (n=35)
Number of subjects: 140
Study 19664956 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical placebo cream and injection of Tc‐sulfur colloid containing sodium bicarbonate (n=35)
Number of subjects: 140
Study 19664956 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical placebo cream and injection of Tc‐sulfur colloid containing 1% lidocaine (n=35)
Number of subjects: 140
Study 19664956 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical placebo cream and injection of Tc‐sulfur colloid containing sodium bicarbonate and 1% lidocaine (n=35)
Number of subjects: 140
Study 17211264 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal Femoral Nail (PFN)
Number of subjects: 203
Study 17211264 — intervention group
Group type: COMPARATOR
Intervention: Medoff Sliding Plate (MSP)
Number of subjects: 203
Study 16398423 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaoshui Decoction (XSD) combined with chemotherapy (DDP via abdominal infusion)
Number of subjects: 61
Study 16398423 — intervention group
Group type: COMPARATOR
Intervention: DDP infusion alone (control group)
Number of subjects: 61
Study 16398423 — intervention group
Group type: EXPERIMENTAL
Intervention: XSD in experimental study (mice models)
Number of subjects: 61
Study 16398423 — intervention group
Group type: COMPARATOR
Intervention: DDP in experimental study (control group for mice)
Number of subjects: 61
Study 12526189 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT)
Number of subjects: 3000
Study 12526189 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 3000
Study 12526189 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective estrogen receptor modulators (SERMs)
Number of subjects: 3000
Study 12526189 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 3000
Study 12526189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study 9690723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg t.d.s.)
Number of subjects: 86
Study 9690723 — intervention group
Group type: COMPARATOR
Intervention: Tripotassium dicitrato bismuthate (TDB) (120 mg q.d.s.)
Number of subjects: 86
Study 8620674 — intervention group
Group type: EXPERIMENTAL
Intervention: Zileuton 800mg twice daily
Number of subjects: 16
Study 8620674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 2703967 — intervention group
Group type: EXPERIMENTAL
Intervention: Methocarbamol 2.25, 4.5, and 9 g
Number of subjects: 14
Study 2703967 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 1, 2, and 4 mg
Number of subjects: 14
Study 2703967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 579342 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolamolol
Number of subjects: 15
Study 30590612 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomy-supportive intervention program for PE teachers over 3 months
Number of subjects: 681
Study 30590612 — intervention group
Group type: COMPARATOR
Intervention: Control group (teachers not receiving the autonomy-supportive intervention)
Number of subjects: 681
Study 30773586 — intervention group
Group type: COMPARATOR
Intervention: Canola oil diet (17.5% MUFAs, 9.2% PUFAs, 6.6% SFAs)
Number of subjects: 119
Study 30773586 — intervention group
Group type: COMPARATOR
Intervention: High-oleic acid canola oil (HOCO) diet (19.1% MUFAs, 7.0% PUFAs, 6.4% SFAs)
Number of subjects: 119
Study 30773586 — intervention group
Group type: COMPARATOR
Intervention: Control oil blend (10.5% MUFAs, 10.0% PUFAs, 12.3% SFAs)
Number of subjects: 119
Study 26559708 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Power Play! Campaign
Number of subjects: 3463
Study 26559708 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3463
Study 25929710 — intervention group
Group type: EXPERIMENTAL
Intervention: Invisalign® aligners
Number of subjects: 50
Study 25929710 — intervention group
Group type: COMPARATOR
Intervention: Fixed brackets
Number of subjects: 50
Study 22982605 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐amphetamine (20mg-oral)
Number of subjects: 0
Study 22982605 — intervention group
Group type: EXPERIMENTAL
Intervention: haloperidol (2mg-oral)
Number of subjects: 0
Study 22982605 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 21888655 — intervention group
Group type: COMPARATOR
Intervention: Methylene blue alone (Group 1)
Number of subjects: 90
Study 21888655 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined technique (sulfur colloid labeled with 99 m Technetium, gamma-probe guided surgery, and methylene blue) (Group 2)
Number of subjects: 90
Study 21888655 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (combined data)
Number of subjects: 90
Study 19168206 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic hysterectomy and lymphadenectomy
Number of subjects: 181
Study 19168206 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic hysterectomy and lymphadenectomy
Number of subjects: 181
Study 16935686 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate 100 mug twice daily
Number of subjects: 200
Study 16935686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 16935686 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate 100 mug twice daily (open-label added if symptoms not controlled)
Number of subjects: 200
Study 12813384 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g bolus before incision, 200 mg/hour infusion during surgery)
Number of subjects: 49
Study 12813384 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 49
Study 12813384 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 49
Study 10855595 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed mood and underweight (BMI < 20)
Number of subjects: 2275
Study 10855595 — intervention group
Group type: COMPARATOR
Intervention: Not depressed and underweight (BMI < 20)
Number of subjects: 2275
Study 10855595 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed mood and normal weight (BMI 20-24.99)
Number of subjects: 2275
Study 10855595 — intervention group
Group type: COMPARATOR
Intervention: Not depressed and normal weight (BMI 20-24.99)
Number of subjects: 2275
Study 10855595 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed mood and overweight (BMI > or = 25)
Number of subjects: 2275
Study 10855595 — intervention group
Group type: COMPARATOR
Intervention: Not depressed and overweight (BMI > or = 25)
Number of subjects: 2275
Study 8707761 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive cytokine and progenitor cell support of hematologic recovery after myelosuppressive therapy
Number of subjects: 0
Study 8707761 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic cytokines active on cells of the leukocyte lineages
Number of subjects: 0
Study 1511228 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine or guanfacine treatment
Number of subjects: 0
Study 1511228 — intervention group
Group type: COMPARATOR
Intervention: Methadone treatment
Number of subjects: 0
Study 6359848 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral verapamil
Number of subjects: 30
Study 30654549 — intervention group
Group type: EXPERIMENTAL
Intervention: Wireless sensor network (WSN) with randomized identifier for location data collection
Number of subjects: 0
Study 30654549 — intervention group
Group type: EXPERIMENTAL
Intervention: Media Access Control (MAC) protocol designed and implemented using beacon-slotted ALOHA mechanism
Number of subjects: 0
Study 28994675 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.4 μg/kg/h continuous infusion
Number of subjects: 150
Study 28994675 — intervention group
Group type: COMPARATOR
Intervention: Dopamine 3 μg/kg/min continuous infusion
Number of subjects: 150
Study 26870843 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal dressing containing colophony, zinc oxide and magnesium oxide applied after scaling and root planing
Number of subjects: 28
Study 26870843 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dressing)
Number of subjects: 28
Study 26870843 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal dressing
Number of subjects: 28
Study 26870843 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (test and control)
Number of subjects: 28
Study 25134117 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplementation
Number of subjects: 318
Study 25134117 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein supplementation
Number of subjects: 318
Study 25134117 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 318
Study 22802974 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 µg rSh28GST with aluminium hydroxide (Alum) as adjuvant (n=8)
Number of subjects: 24
Study 22802974 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 µg rSh28GST (n=8)
Number of subjects: 24
Study 22802974 — intervention group
Group type: COMPARATOR
Intervention: Alum alone (n=8)
Number of subjects: 24
Study 19006541 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine effervescent tablets 75 mg (on-demand)
Number of subjects: 103
Study 19006541 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole capsules 15 mg (on-demand)
Number of subjects: 103
Study 17768579 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (600 mg/day to 900 mg/day intravenously on the first postoperative day, followed by 400 mg/day orally until hospital discharge or until completing seven days)
Number of subjects: 68
Study 17768579 — intervention group
Group type: COMPARATOR
Intervention: Control (no prophylaxis with amiodarone)
Number of subjects: 68
Study 17768579 — intervention group
Group type: COMPARATOR
Intervention: Non-randomized individuals (with two or fewer risk factors)
Number of subjects: 68
Study 15010730 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation with phorbol 12‐myristate 13‐acetate and ionomycin
Number of subjects: 0
Study 15010730 — intervention group
Group type: EXPERIMENTAL
Intervention: No stimulation
Number of subjects: 0
Study 15010730 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation for 24 h
Number of subjects: 0
Study 12169323 — intervention group
Group type: EXPERIMENTAL
Intervention: cnMUPs (concentric needle EMG)
Number of subjects: 21
Study 12169323 — intervention group
Group type: EXPERIMENTAL
Intervention: mMUPs (macro-EMG)
Number of subjects: 21
Study 11350207 — intervention group
Group type: EXPERIMENTAL
Intervention: D-tagatose (3x15 g daily)
Number of subjects: 12
Study 11350207 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sucrose, 3x15 g daily)
Number of subjects: 12
Study 9229235 — intervention group
Group type: EXPERIMENTAL
Intervention: s/c GLP-1 40 nmol, given three times a day immediately before meals
Number of subjects: 5
Study 9229235 — intervention group
Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 5
Study 8235104 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser indirect ophthalmoscope (LIO)
Number of subjects: 9
Study 8235104 — intervention group
Group type: COMPARATOR
Intervention: Argon laser indirect ophthalmoscope (LIO)
Number of subjects: 9
Study 3306730 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypohydration at 0%, 3%, 5%, and 7% body weight loss
Number of subjects: 7
Study 3306730 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad lib drinking during hypohydration
Number of subjects: 7
Study 3306730 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid intake prediction
Number of subjects: 7
Study 3306730 — intervention group
Group type: EXPERIMENTAL
Intervention: Thirst sensations
Number of subjects: 7
Study 29057502 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital photographic reference scales for evaluating facial aging signs
Number of subjects: 750
Study 27162449 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex‐PRESS device implantation (model P50)
Number of subjects: 26
Study 27162449 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 26
Study 27162449 — intervention group
Group type: COMPARATOR
Intervention: Ex‐PRESS group vs Trabeculectomy group
Number of subjects: 26
Study 25400667 — intervention group
Group type: EXPERIMENTAL
Intervention: Royal Jelly (RJ) applied three times per day during treatment
Number of subjects: 13
Study 25400667 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RJ)
Number of subjects: 13
Study 23299850 — intervention group
Group type: EXPERIMENTAL
Intervention: Single injection of PRP (Group A)
Number of subjects: 78
Study 23299850 — intervention group
Group type: EXPERIMENTAL
Intervention: Two injections of PRP (Group B)
Number of subjects: 78
Study 23299850 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group C)
Number of subjects: 78
Study 20225605 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0
Study 20225605 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk assessments
Number of subjects: 0
Study 20225605 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy considerations
Number of subjects: 0
Study 18461102 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavone-rich soy protein (Soy+)
Number of subjects: 30
Study 18461102 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavone-poor soy protein (Soy-)
Number of subjects: 30
Study 18461102 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk protein (Milk)
Number of subjects: 30
Study 15937693 — intervention group
Group type: COMPARATOR
Intervention: Appendectomy in UC
Number of subjects: 382
Study 15937693 — intervention group
Group type: COMPARATOR
Intervention: Appendectomy in CD
Number of subjects: 382
Study 15937693 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking in UC
Number of subjects: 382
Study 15937693 — intervention group
Group type: EXPERIMENTAL
Intervention: OCP and NSAID use in UC
Number of subjects: 382
Study 15937693 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy
Number of subjects: 382
Study 12932675 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian carcinoma patients
Number of subjects: 40
Study 10867980 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine hydrochloride 0.2 mg
Number of subjects: 16
Study 10867980 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine hydrochloride 22 mg
Number of subjects: 16
Study 10867980 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine hydrochloride 0.2 mg + Yohimbine hydrochloride 22 mg
Number of subjects: 16
Study 9031988 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 0.5 mg
Number of subjects: 50
Study 9031988 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 50
Study 9031988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg
Number of subjects: 50
Study 9031988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 10 mg
Number of subjects: 50
Study 9031988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 1590547 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 g/kg dose of ethanol
Number of subjects: 40
Study 1590547 — intervention group
Group type: COMPARATOR
Intervention: Placebo dose
Number of subjects: 40
Study 29336029 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain-responsive neurostimulation (RNS System)
Number of subjects: 707
Study 26547540 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult eczema
Number of subjects: 47611
Study 26547540 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood eczema
Number of subjects: 47611
Study 25383795 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening Families Program: For Parents and Youth Ages 10-14 (SFP 10-14)
Number of subjects: 252
Study 22594461 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg) 0.4 U/kg once daily
Number of subjects: 54
Study 22594461 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (IGlar) 0.4 U/kg once daily
Number of subjects: 54
Study 20538838 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg
Number of subjects: 24
Study 20538838 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg
Number of subjects: 24
Study 20538838 — intervention group
Group type: COMPARATOR
Intervention: N-acetylcysteine (NAC) 600 mg (healthy control)
Number of subjects: 24
Study 18335014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling vest
Number of subjects: 10
Study 18335014 — intervention group
Group type: COMPARATOR
Intervention: No cooling vest
Number of subjects: 10
Study 16521032 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine infusions (0, 8, 16, and 32 mg/70 kg)
Number of subjects: 14
Study 16521032 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine infusions (16 mg)
Number of subjects: 14
Study 12724276 — intervention group
Group type: EXPERIMENTAL
Intervention: VCY2 antibody
Number of subjects: 0
Study 12724276 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 10881609 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulatory suppression with irrelevant speech suffix
Number of subjects: 0
Study 10881609 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrelevant speech during list presentation
Number of subjects: 0
Study 10881609 — intervention group
Group type: EXPERIMENTAL
Intervention: Different items as irrelevant speech
Number of subjects: 0
Study 9505982 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg hydrocodone bitartrate with 400 mg ibuprofen
Number of subjects: 120
Study 9505982 — intervention group
Group type: COMPARATOR
Intervention: 400 mg ibuprofen
Number of subjects: 120
Study 9505982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 8211428 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 40
Study 8211428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 3516291 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of apomorphine
Number of subjects: 12
Study 3516291 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of apomorphine
Number of subjects: 12
Study 3516291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31368284 — intervention group
Group type: EXPERIMENTAL
Intervention: Body acupuncture combined with auricular acupuncture
Number of subjects: 111
Study 31368284 — intervention group
Group type: COMPARATOR
Intervention: Body acupuncture (control group)
Number of subjects: 111
Study 29456025 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert-driven e-counseling
Number of subjects: 128
Study 29456025 — intervention group
Group type: EXPERIMENTAL
Intervention: User-driven e-counseling
Number of subjects: 128